Rang	Name	Position
1	Dr. Bahram Valamehr M.B.A., Ph.D.	President, CEO & Director
2	Mr. Kamal Adawi M.S., MBA	CFO & Treasurer
3	Ms. Cindy R. Tahl J.D.	Chief Legal & Compliance Officer and Corporate Secretary
4	Ms. Jessica Francis	Senior Vice President of Human Resources & Operations
5	Dr. Martin Hosking	Head of Research
6	Dr. Tunde Babalola Ph.D.	Senior Vice President of Technical Operations & Quality
7	Mr. Ryan Douglas	Senior Director of Investor Relations & Business Development
8	Mr. Andrew Henry	Senior Vice President of Clinical Operations
9	Dr. Yu Cai J.D., Ph.D.	Head of Intellectual Property & Assistant General Counsel
10	Ms. Kate Duvall	Corporate Controller

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Redmile Group, LLC	10,74%	29,74 Mio. USD
2	BlackRock Inc	8,40%	23,26 Mio. USD
3	Vanguard Capital Management, LLC	3,50%	9,68 Mio. USD
4	Vanguard Portfolio Management, LLC	3,45%	9,55 Mio. USD
5	Acadian Asset Management LLC	3,44%	9,52 Mio. USD
6	Two Sigma Investments LLC	3,00%	8,29 Mio. USD
7	Johnson & Johnson	2,82%	7,81 Mio. USD
8	AQR Capital Management LLC	2,51%	6,93 Mio. USD
9	Renaissance Technologies Corp	2,48%	6,87 Mio. USD
10	Geode Capital Management, LLC	2,16%	5,98 Mio. USD
11	Millennium Management LLC	2,03%	5,62 Mio. USD
12	State Street Corp	1,89%	5,23 Mio. USD
13	UBS Group AG	1,52%	4,21 Mio. USD
14	The Goldman Sachs Group Inc	1,11%	3,07 Mio. USD
15	TANG CAPITAL MANAGEMENT LLC	0,97%	2,70 Mio. USD
16	Citadel Advisors Llc	0,83%	2,30 Mio. USD
17	Irenic Capital Management LP	0,73%	2,03 Mio. USD
18	Northern Trust Corp	0,68%	1,88 Mio. USD
19	Bruce & Co Inc	0,66%	1,82 Mio. USD
20	Morgan Stanley - Brokerage Accounts	0,64%	1,77 Mio. USD